tiprankstipranks
Trending News
More News >
Hangzhou Tigermed Consulting Co., Ltd. Class H (DE:5HZ1)
FRANKFURT:5HZ1
Germany Market

Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Financial Statements

Compare
1 Followers

Hangzhou Tigermed Consulting Co., Ltd. Class H Financial Overview

Hangzhou Tigermed Consulting Co., Ltd. Class H's market cap is currently €4.49B. The company's EPS TTM is €0.022670431; its P/E ratio is 80.49; and it has a dividend yield of 1.89%. Hangzhou Tigermed Consulting Co., Ltd. Class H is scheduled to report earnings on April 29, 2025, and the estimated EPS forecast is €0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 6.60B¥ 7.38B¥ 7.09B¥ 5.21B¥ 3.19B
Gross Profit¥ 2.24B¥ 2.85B¥ 2.81B¥ 2.27B¥ 1.51B
Operating Income¥ 664.42M¥ 2.49B¥ 2.58B¥ 1.92B¥ 1.12B
EBITDA¥ 1.13B¥ 2.91B¥ 2.42B¥ 2.11B¥ 1.27B
Net Income¥ 405.14M¥ 2.02B¥ 2.01B¥ 2.87B¥ 1.75B
Balance Sheet
Cash & Short-Term Investments¥ 2.13B¥ 7.46B¥ 7.88B¥ 8.57B¥ 10.15B
Total Assets¥ 28.67B¥ 29.68B¥ 27.45B¥ 23.74B¥ 19.51B
Total Debt¥ 2.63B¥ 2.83B¥ 2.80B¥ 1.19B¥ 384.94M
Net Debt¥ 579.64M¥ -4.59B¥ -5.06B¥ -7.35B¥ -9.74B
Total Liabilities¥ 4.61B¥ 5.23B¥ 4.77B¥ 3.14B¥ 1.65B
Stockholders' Equity¥ 20.67B¥ 21.03B¥ 19.58B¥ 18.12B¥ 16.12B
Cash Flow
Free Cash Flow¥ 740.45M¥ 836.68M¥ 908.90M¥ 1.06B¥ 842.18M
Operating Cash Flow¥ 1.10B¥ 1.15B¥ 1.36B¥ 1.42B¥ 998.68M
Investing Cash Flow-¥ -1.53B---
Financing Cash Flow-¥ -7.81M¥ 809.25M-¥ 9.34B
Currency in CNY

Hangzhou Tigermed Consulting Co., Ltd. Class H Earnings and Revenue History

Hangzhou Tigermed Consulting Co., Ltd. Class H Debt to Assets

Hangzhou Tigermed Consulting Co., Ltd. Class H Cash Flow

Hangzhou Tigermed Consulting Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis